HIV Home
QDMRK
About Enrolling
REALMRK
About Enrolling
BENCHMRK
About Enrolling
STARTMRK
About Enrolling
About this Study
Condition
Intervention
Phase
Human Immunodeficiency Virus
Drug: MK-0518
Phase III
ENROLLMENT IN THIS STUDY IS CLOSED.
REALMRK
You may be eligible for the study if you are:
HIV positive and 16 years of age or older.
Participation in this one-year study includes at no cost:
Study-related doctor visits
Investigational study drug
Laboratory testing
In many cases, reimbursement for transportation and childcare may be available.
Printable Version
Copyright © 2005-2007 Merck & Co., Inc., All rights reserved.
